-
NASH
Coming Soon! NASH is a quiet liver disease that often shows no symptoms until it's severe. It starts with extra liver fat and can lead to serious liver damage. Early action is key to preventing it from getting worse.
Read more
Criteria & Qualifications: • Must be between 18 and 75 years old, and can be either a man or a woman.
• Must be obese with a BMI of 27 or higher.
• Diagnosed with Fatty Liver Disease.
Compensation: Contact us for more information -
Respiratory Syncytial Virus (RSV)
Coming Soon! If you're 60 or older and want to help medical research, you could join a study testing a new vaccine for a lung disease.
Read more
Criteria & Qualifications: • You must be at least 60 years old.
• You should be able to take care of yourself and manage day-to-day activities.
• If you have chronic health conditions like heart or lung problems, they should be stable.
Compensation: Contact us for more information -
Kidney Disease
This study checks a new treatment for severe kidney disease with hormone issues. It has two parts: one with real and fake treatments, and one where all get the real treatment. Doctors will test the results.
Read more
Criteria & Qualifications: • Age 18-80.
• On hemodialysis 3x a week for 3+ months.
Compensation: Contact us for more information -
Inflammatory Bowel Disease (IBD)
We invite you to participate in a study to assess the safety and effectiveness of a new oral medication, compared to a standard control, for treating and maintaining stable conditions in individuals with Inflammatory Bowel Disease (IBD).
Read more
Criteria & Qualifications: • Must be 18 years of age or older.
• Diagnosis of Crohn’s disease or Ulcerative Colitis.
Compensation: Contact us for more information -
Eosinophilic Asthma
Coming Soon! We're checking if switching treatments for people with severe eosinophilic asthma works as well as their current medication. Everyone taking part will continue with their usual asthma care. Join us to help advance eosinophilic asthma treatment!
Read more
Criteria & Qualifications: • More than 12 Years and older.
Compensation: Contact us for more information -
Crohn’s Disease Study
We're offering a study to test a new treatment for severe Crohn's Disease, especially for those who didn't benefit from common treatments. Participants will be divided into groups; some will receive the actual treatment, others a placebo. Those showing significant improvement in the early phase will continue to the next part of the study. Join us to help advance Crohn's Disease research!
Read more
Criteria & Qualifications: • Is at least 18 years of age or older
Compensation: Contact us for more information -
COVID-19 Study
Interested in our COVID-19 study? We're testing treatments for non-hospitalized patients. You'll get treatment and safety checks. Follow-ups last weeks to months. Help us fight COVID-19!
Read more
Criteria & Qualifications: • COVID-19 positive in the last 10 days.
• Experienced COVID-19 symptoms within 7 days, like fever, cough, trouble breathing, sore throat, body pain, tiredness, headache, stuffy nose, loss of taste/smell, stomach issues, or high temperature.
• Had one or more symptoms in the last 24 hours.
Compensation: Contact Us for more information -
Device Study
Coming Soon! Introducing our multi-target Rapid Antigen Test, designed to detect the presence of specific viral antigens associated with COVID-19, Flu A, Flu B, and RSV (Respiratory Syncytial Virus). This streamlined test offers the unique advantage of identifying multiple respiratory pathogens simultaneously, enabling timely diagnosis and management of infections.
Read more
Criteria & Qualifications: • Individuals should be above 18 years of age.
• Those showing symptoms of respiratory infections or having had contact with confirmed cases.
Compensation: Contact us for more information -
Ulcerative Colitis Study
Coming Soon! Ulcerative Colitis causes inflammation and ulcers in the colon, resulting in abdominal discomfort. This study evaluates a new treatment's efficacy and safety for those with moderate to severe conditions. It targets individuals unsatisfied with or affected by current therapies' side effects.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Diagnosed with Ulcerative Colitis.
• Is willing to provide medical records.
Compensation: Contact Us For More information -
Ulcerative Colitis Study
Coming Soon! Ulcerative Colitis is a type of IBD that causes inflammation, sores, and abdominal pain. This clinical trial is being conducted to evaluate the safety and efficacy of an investigational Alfa Induction Therapy in people with Ulcerative Colitis.
Read more
Criteria & Qualifications: • Is at least 16 years of age or older.
• Is willing to provide medical records.
Compensation: Contact us for more information -
Systemic Lupus Erythematosus
Coming Soon! Systemic Lupus Erythematosus (SLE) is a complex autoimmune disorder where the body mistakenly attacks its tissues. This phase 1 clinical trial aims to assess the safety, dosage, and side effects of a novel treatment for SLE in a controlled group, paving the way for effective, targeted therapies.
Read more
Criteria & Qualifications: • More than 18 years.
Compensation: Contact us for more information -
COVID-19
Test if the drug is safe and effective for the treatment of coronavirus disease 2019 (COVID-19) in participants who have a standard risk of developing severe illness.
Read more
Criteria & Qualifications: • Between 12- 64 years old.
• Infected with COVID-19 within the last 3 days.
Compensation: Up to $1600
